AAV
$810 Million Turned Into a Rare Disease Revolution with Japan’s Nippon Shinyaku’s and USA’s REGENXBIO’s Partnership
2025-01-21
Serious Adverse Event in Study Participant Marks Latest Roadblock for Astellas’ Gene Therapy Trial
2021-09-03
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28